Search research articles
Contact Us
Filters
Showing results (1-10 of 119) with videos related to
Page
of 12
Sort By:
Cancers
|
November 26, 2020
Shaping the Treatment Paradigm Based on the Current Understanding of the Pathobiology of Multiple Myeloma: An Overview
Slavisa Ninkovic, Hang Quach
Current Opinion in Oncology
|
September 9, 2024
Biomarker-directed therapy in multiple myeloma
Adam Bryant, Hang Quach
Cancers
|
August 14, 2025
The Evolving Treatment Landscape for the Elderly Multiple Myeloma Patient: From Quad Regimens to T-Cell Engagers and CAR-T
Matthew James Rees, Hang Quach
Haematologica
|
November 4, 2005
Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab
Hang Quach, Henry Januszewicz, David Westerman
American Journal of Hematology
|
May 30, 2012
Lenalidomide in multiple myeloma: Current status and future potential
Hang Quach, Anna Kalff, Andrew Spencer
Haematologica
|
December 24, 2025
Translocation t(11;14) and BCL2-inhibition in multiple myeloma
Shirlene Sim, Binod Dhakal, Hang Quach
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
May 28, 2011
Reversal of transfusion dependence by tumor necrosis factor inhibitor treatment in a patient with concurrent rheumatoid arthritis and primary myelofibrosis
Anderson Ong, Hang Quach, Michelle Leech
Expert Review of Hematology
|
September 29, 2020
Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma
Slavisa Ninkovic, Simon J Harrison, Hang Quach
Expert Review of Hematology
|
June 15, 2011
Managing multiple myeloma in the elderly: are we making progress?
Hang Quach, H Miles Prince, Andrew Spencer
Clinical Lymphoma, Myeloma & Leukemia
|
August 4, 2020
Perspectives in the Rapidly Evolving Treatment Landscape of Multiple Myeloma: Expert Review of New Data Presentations from ASH 2019
Chng Wee Joo, Hang Quach, Noopur Raje
Page
of 12
Search research articles
Search
Showing results (1-10 of 119) with videos related to
Sort By:
Page
of 12
Cancers
|
November 26, 2020
Shaping the Treatment Paradigm Based on the Current Understanding of the Pathobiology of Multiple Myeloma: An Overview
Slavisa Ninkovic, Hang Quach
Current Opinion in Oncology
|
September 9, 2024
Biomarker-directed therapy in multiple myeloma
Adam Bryant, Hang Quach
Cancers
|
August 14, 2025
The Evolving Treatment Landscape for the Elderly Multiple Myeloma Patient: From Quad Regimens to T-Cell Engagers and CAR-T
Matthew James Rees, Hang Quach
Haematologica
|
November 4, 2005
Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab
Hang Quach, Henry Januszewicz, David Westerman
American Journal of Hematology
|
May 30, 2012
Lenalidomide in multiple myeloma: Current status and future potential
Hang Quach, Anna Kalff, Andrew Spencer
Haematologica
|
December 24, 2025
Translocation t(11;14) and BCL2-inhibition in multiple myeloma
Shirlene Sim, Binod Dhakal, Hang Quach
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
May 28, 2011
Reversal of transfusion dependence by tumor necrosis factor inhibitor treatment in a patient with concurrent rheumatoid arthritis and primary myelofibrosis
Anderson Ong, Hang Quach, Michelle Leech
Expert Review of Hematology
|
September 29, 2020
Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma
Slavisa Ninkovic, Simon J Harrison, Hang Quach
Expert Review of Hematology
|
June 15, 2011
Managing multiple myeloma in the elderly: are we making progress?
Hang Quach, H Miles Prince, Andrew Spencer
Clinical Lymphoma, Myeloma & Leukemia
|
August 4, 2020
Perspectives in the Rapidly Evolving Treatment Landscape of Multiple Myeloma: Expert Review of New Data Presentations from ASH 2019
Chng Wee Joo, Hang Quach, Noopur Raje
Page
of 12